BIVI - BIOVIE INC.
1.36
0.020 1.471%
Share volume: 30,569
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.26%
PREVIOUS CLOSE
CHG
CHG%
$1.34
0.02
0.01%
View ratios
| Fiscal Date | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q4 2024 | Q1 2024 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
| Report Date | 11-13-2024 | 11-13-2024 | 02-11-2025 | 05-12-2025 | 08-15-2025 | 11-10-2025 | 02-06-2026 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | |||||
| Operating expenses | 0.000 | 4.065 M | 7.235 M | 2.931 M | 0.000 | 5.227 M | 6.205 M | |
| Selling general and admin | 0.000 | 2.075 M | 2.531 M | 1.586 M | 0.000 | 2.291 M | 1.935 M | |
| Research and development | 0.000 | 1.990 M | 4.705 M | 1.345 M | 0.000 | 2.936 M | 4.269 M | |
| Total expenses | 0.000 | 4.122 M | 7.293 M | 2.988 M | 0.000 | 5.285 M | 6.262 M | |
| 76.92% | -59.03% | -100.00% | 18.50% | |||||
| Operating income | 0.000 | -4.122 M | -7.293 M | -2.988 M | 0.000 | -5.285 M | -6.262 M | |
| Ebit | 0.000 | -4.120 M | -7.299 M | -2.981 M | 0.000 | -5.285 M | -6.262 M | |
| Pretax income | 0.000 | -4.477 M | -7.157 M | -2.788 M | 0.000 | -5.088 M | -6.069 M | |
| 59.86% | -61.04% | -100.00% | 19.30% | |||||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | 0.000 | -4.152 M | -7.113 M | -2.788 M | 0.000 | -5.088 M | -6.069 M | |
| -71.30% | 60.80% | 100.00% | -19.30% |